News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,223 Results
Type
Article (29)
Press Release (3194)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Allergies (1)
Alliances (44)
Alzheimer's disease (30)
Approvals (110)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (297)
Breast cancer (10)
Cancer (85)
Cardiovascular disease (6)
Career advice (1)
Cervical cancer (1)
Clinical research (665)
Collaboration (4)
Compensation (3)
COVID-19 (4)
Data (106)
Diabetes (1)
Diagnostics (22)
Drug discovery (1)
Drug pricing (1)
Earnings (1502)
Events (344)
FDA (152)
Frontotemporal dementia (1)
Funding (4)
Generative AI (1)
Gene therapy (4)
GLP-1 (8)
Government (9)
Guidances (24)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (161)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (35)
Lymphoma (10)
Manufacturing (1)
MASH (4)
Medical device (57)
Medtech (57)
Mergers & acquisitions (26)
Metabolic disorders (6)
Multiple sclerosis (3)
NASH (1)
Neuroscience (39)
NextGen: Class of 2025 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (1)
Pancreatic cancer (1)
Parkinson's disease (1)
Peanut (1)
People (8)
Phase I (100)
Phase II (199)
Phase III (396)
Pipeline (95)
Policy (1)
Postmarket research (27)
Preclinical (13)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (6)
Regulatory (148)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (2)
Schizophrenia (3)
Sponsored (1)
Startups (3)
Vaccines (5)
Date
Today (1)
Last 7 days (5)
Last 30 days (28)
Last 365 days (440)
2025 (306)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (349)
Australia (13)
California (76)
Canada (24)
China (18)
Connecticut (5)
Delaware (19)
Europe (640)
Florida (11)
Georgia (2)
Illinois (8)
Indiana (18)
Japan (12)
Maryland (17)
Massachusetts (64)
Minnesota (7)
New Jersey (68)
New York (34)
North Carolina (11)
Northern California (54)
Ohio (3)
Pennsylvania (30)
South America (5)
Southern California (16)
Texas (14)
United States (392)
Utah (7)
Washington State (5)
3,223 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
Rosnilimab Shows Promise as a Potential Next-Generation RA Therapy
A depleter of pathogenic T cells, rosnilimab’s novel MOA generated a differentiated efficacy, tolerability and safety profile in recent Phase 2b study
September 15, 2025
·
7 min read
Press Releases
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
September 1, 2025
·
14 min read
Press Releases
New data for Roche’s Vabysmo reinforce its efficacy, safety and durability in neovascular or “wet” age-related macular degeneration (nAMD)
September 5, 2025
·
13 min read
Press Releases
Takeda’s FRUZAQLA™ (fruquintinib) publicly reimbursed in Quebec for the treatment of metastatic colorectal cancer (mCRC)
August 29, 2025
·
5 min read
Press Releases
Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)
September 15, 2025
·
8 min read
Press Releases
Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
September 1, 2025
·
17 min read
Press Releases
Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program
August 28, 2025
·
7 min read
Press Releases
Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension
September 1, 2025
·
11 min read
Press Releases
IDEAYA Biosciences and Hengrui Pharma Present Positive Phase 1 Data for IDE849 (SHR-4849), a Potential First-in-Class DLL3 TOP1 ADC, in Small Cell Lung Cancer at the IASLC 2025 World Conference on Lung Cancer
September 8, 2025
·
7 min read
Press Releases
Scancell reports Business Update and Financial Results for the Year Ended 30 April 2025
September 11, 2025
·
43 min read
1 of 323
Next
